👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

China’s Stock Market Suffers The Least In Global Equities Sell-Off

Published 03/13/2020, 07:32 AM
Updated 07/09/2023, 06:31 AM
SPY
-
MCHI
-
VT
-

China has been the epicenter for the coronavirus outbreak, but its stock market is suffering the least on a year-to-date basis through yesterday’s close (Mar. 12) for the world’s major equity market regions, based on a set of exchange traded funds.

The iShares MSCI China ETF (NASDAQ:MCHI) has lost 13.7% so far in 2020 through yesterday’s close. That’s a painful setback but it’s relatively modest compared with the rest of the field.

The global equity benchmark — Vanguard Total World Stock Index Fund ETF Shares (NYSE:VT) – is down nearly twice as much, posting a 25.4% year-to-date loss. The U.S. market — in sharp contrast from a month ago — is down 22.9% in 2020 via SPDR S&P 500 (NYSE:SPY). The worst-hit region: Latin America, which is groaning under a 43.1% collapse so far this year.

Why is the sell-off relatively modest for China’s stock market? “We’re better off than offshore markets in terms of virus outbreak containment, lower overall valuations and bigger policy room,” opines Dai Ming, a fund manager with Hengsheng Asset Management Co. in Shanghai. “Chinese stocks will fare better than global peers despite some short-term pullback,” he predicts.

Equity Markets Performance YTD

Recent data on China’s coronavirus outbreak suggest that infections may be peaking. Reuters today reports:

China’s Wuhan city, ground zero of the new coronavirus outbreak, reported five new cases on Friday, the second day in a row the tally has been less than 10, while no locally transmitted infections were reported in the rest of the country.

Mi Feng, a spokesman for China’s National Health Commission, says “broadly speaking, the peak of the epidemic has passed for China. The increase of new cases is falling.”

For much of the rest of the world, including the U.S. and Europe, the outbreak is at an earlier stage. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the U.S., in testimony to Congress this week advised: “I can say we will see more cases and things will get worse than they are right now.”

Profiling all the funds listed above through a momentum lens reflects broad weakness in the wake of the widespread selloff. The analysis is based on two sets of moving averages, which point to a sharp deterioration for global shares on the short-term front. The first measure compares the 10-day average with its 100-day counterpart — a proxy for short-term trending behavior (red line in chart below). A second set of moving averages (50 and 200 days) represent an intermediate measure of the trend (blue line). Based on data through yesterday’s close, the outlook has turned sharply bearish for the short-term outlook although the intermediate trend has yet to confirm the downside bias.Global Equities Diffusion Index

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.